|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2000-1-10
|
|
pubmed:abstractText |
To evaluate a hyperfractionated and accelerated radiotherapy (HART) protocol in patients with inoperable non-small cell lung carcinoma (NSCLC) who were ineligible for combination radiochemotherapy studies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1151-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10613307-Adenocarcinoma,
pubmed-meshheading:10613307-Adult,
pubmed-meshheading:10613307-Aged,
pubmed-meshheading:10613307-Carcinoma, Large Cell,
pubmed-meshheading:10613307-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:10613307-Carcinoma, Squamous Cell,
pubmed-meshheading:10613307-Disease-Free Survival,
pubmed-meshheading:10613307-Dose Fractionation,
pubmed-meshheading:10613307-Female,
pubmed-meshheading:10613307-Humans,
pubmed-meshheading:10613307-Lung Neoplasms,
pubmed-meshheading:10613307-Male,
pubmed-meshheading:10613307-Middle Aged,
pubmed-meshheading:10613307-Survival Rate,
pubmed-meshheading:10613307-Time Factors
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
